Back to Search Start Over

Effects of tirofiban on large vessel occlusion stroke are modified by etiology and renal function.

Authors :
Liu C
Li F
Chen L
Huang J
Sang H
Nguyen TN
Saver JL
Abdalkader M
Kong W
Yang J
Guo C
Gong C
Huang L
Pan Y
Wang X
Chen Y
Qiu Z
Zi W
Source :
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Mar; Vol. 11 (3), pp. 618-628. Date of Electronic Publication: 2023 Dec 29.
Publication Year :
2024

Abstract

Objective: Renal function can modify the outcomes of large vessel occlusion (LVO) stroke across stroke etiologies in disparate degrees. The presence of renal function deficit can also impair the pharmacokinetics of tirofiban. Hence, this study aimed to investigate the roles of renal function in determining efficacy and safety of intravenous tirofiban before endovascular treatment (EVT) for acute ischemic stroke patients with large vessel occlusion (LVO).<br />Methods: This study was a post hoc exploratory analysis of the RESCUE-BT trial. The primary outcome was the proportion of patients achieving functional independence (modified Rankin scale 0-2) at 90 days, and the primary safety outcome was the rate of symptomatic intracranial hemorrhage (sICH).<br />Results: Among 908 individuals with available serum creatinine, decreased estimated glomerular filtration rate (eGFR) status was noted more commonly in patients with cardioembolic stroke (CE), while large artery atherosclerosis (LAA) was predominant in patients with normal renal function. In LAA with normal renal function, tirofiban was associated with higher rates of functional independence at 90 days (41.67% vs 59.80%, p = 0.003). However, for LVO patients with renal dysfunction, tirofiban did not improve functional outcomes for any of the etiologies (LAA, p = 0.876; CE, p = 0.662; others, p = 0.894) and significantly increased the risk of sICH among non-LAA patients (p = 0.020). Mediation analysis showed tirofiban reduced thrombectomy passes (12.27%) and drug/placebo to recanalization time (14.25%) mediated its effects on functional independence.<br />Conclusion: This present study demonstrated the importance of evaluating renal function before administering intravenous tirofiban among patients with LVO who are planned to undergo EVT.<br /> (© 2023 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.)

Details

Language :
English
ISSN :
2328-9503
Volume :
11
Issue :
3
Database :
MEDLINE
Journal :
Annals of clinical and translational neurology
Publication Type :
Academic Journal
Accession number :
38156359
Full Text :
https://doi.org/10.1002/acn3.51982